The Role of the Pharmacist in Treating Patients With CTCL

Name: The Role of the Pharmacist in Treating Patients With CTCL
Uploaded: 2021-09-30T12:00:00.000Z
Description: Lauren C. Pinter-Brown, MD, FACP, of UCI Health and Chao Family Comprehensive Cancer Center, explains what the role of the pharmacist is during the treatment of patients with advanced cutaneous T cell lymphoma.

September 30, 2021

Video

Conference|Society of Hematologic Oncology (SOHO) Annual Meeting

Lauren C. Pinter-Brown, MD, FACP, of UCI Health and Chao Family Comprehensive Cancer Center, explains what the role of the pharmacist is during the treatment of patients with advanced cutaneous T cell lymphoma.

Pharmacy Times interviewed Lauren C. Pinter-Brown, MD, FACP, professor in the Department of Dermatology and the Department of Medicine in the Division of Hematology and Oncology at UCI Health and Chao Family Comprehensive Cancer Center, on her recent presentation at the Society of Hematologic Oncology Annual Meeting 2021 conference on the treatment of advanced cutaneous T cell lymphoma (CTCL) in 2021.

During this discussion, Pinter-Brown explains what the role of the pharmacist is during the treatment of patients with CTCL.